Overview

Neuramis® Volume Lidocaine for Volume Augmentation in the Mid-Face

Status:
Completed
Trial end date:
2020-03-09
Target enrollment:
Participant gender:
Summary
To evaluate the effectiveness and safety of Neuramis® Volume Lidocaine for volume augmentation in the mid-face.
Phase:
N/A
Details
Lead Sponsor:
Medy-Tox
Treatments:
Lidocaine